In an unlikely alliance, the Pharmaceutical Research and Manufacturers of America and “true” safety-net providers represented by the National Association of Community Health Centers have found common ground on legislative principles that would both establish and clarify parameters around the 340B drug discount program.
Dubbed the “Alliance to Save America’s 340B Program” (ASAP 340B), the initiative announced 9 March is a pragmatic approach to...






